Table 1 General demographic, clinical and laboratory characteristics of individuals with and without hyperuricemia
With hyperuricemia N = 558 | Without Hyperuricemia N = 5899 | p-value | |
|---|---|---|---|
Age (y) | 50.73 ± 8.13* | 48.22 ± 8.17 | <0.001 |
Gender Male, n (%) | 244 (43.72) ** | 2335(39.58) | 0.03 |
Education University educated n (%) | 38(6.8) | 392(6.6) | 0.46 |
BMI (kg/m2) | 30.15 ± 4.63 | 27.78 ± 4.68 | <0.001 |
Waist circumference (cm) | 99.31 ± 11.36 | 94.46 ± 12.15 | <0.001 |
SBP (mmHg) | 128.27 ± 20.84 | 121.82 ± 18.31 | <0.001 |
DBP (mmHg) | 82.66 ± 11.83 | 79.24 ± 10.95 | <0.001 |
PAL | 13.29 ± 2.46 | 13.81 ± 2.51 | <0.001 |
History of chronic disease n (%) CVD Diabetes HTN Dyslipidemia | 85(15.2) 65(11.6) 192(34.4) 190(34) | 533(9) 687(11.6) 1055(17.9) 1271(21.5) | < 0.001 0.51 < 0.001 < 0.001 |
Serum uric acid (mol/L) | 439.20 ± 92.61 | 264.93 ± 65.46 | <0.001 |
LDL cholesterol (mg/dl) | 119.10 ± 41.66 | 116.14 ± 34.65 | 0.10 |
HDL cholesterol (mg/dl) | 42.44 ± 10.30 | 43.21 ± 9.98 | 0.08 |
Triglycerides (mg/dl) | 199.89 ± 128.41 | 137.10 ± 83.23 | <0.001 |
EDIR | 0.37 ± 0.34 | 0.41 ± 0.42 | 0.02 |
ELIR | 1.76 ± 0.32 | 1.69 ± 0.38 | <0.001 |
TyG | 8.98 ± 0.59 | 8.56 ± 0.64 | < 0.001 |
TyG-BMI | 271.34 ± 46.74 | 238.72 ± 47.50 | < 0.001 |
TG-HDL ratio | 5.15 ± 3.98 | 3.46 ± 2.59 | <0.001 |
METS-IR | 48.19 ± 8.43 | 42.80 ± 8.71 | <0.001 |
TyG | 8.98 ± 0.59 | 8.56 ± 0.64 | <0.001 |
TyG-BMI | 271.34 ± 46.74 | 238.72 ± 47.50 | <0.001 |
TG-HDL ratio | 5.15 ± 3.98 | 3.46 ± 2.59 | <0.001 |
METS-IR | 48.19 ± 8.43 | 42.80 ± 8.71 | <0.001 |